Sitagliptin/metforminklorid MSN 50 mg/850 mg filmom obložene tablete
| Name | Sitagliptin/metforminklorid MSN 50 mg/850 mg filmom obložene tablete |
|---|---|
| Marketing Authorisation Number | HR-H-072929113 |
| Active Substance | sitagliptinklorid metforminklorid |
| Composition | jedna tableta sadrži 50 mg sitagliptina u obliku sitagliptinklorida i 850 mg metforminklorida |
| Pharmaceutical Form | Filmom obložena tableta |
| Manufacturer | Pharmadox Healthcare Limited, Paola, Malta
MSN Labs Europe Limited, Paola, Malta |
| Marketing Authorisation Holder | MSN Labs Europe Limited, Kw20a Corradino Park, Paola, Malta |
| Marketing Authorisation Date | 03.07.2026 |
| MA Period of Validity | 03.07.2031 |
| Classification Number | UP/I-530-09/22-01/126 |
| Registration Number | 381-12-01/171-26-11 |
| Prescription | Medicinal product subject to medical prescription |
| Type of prescription | Medicinal product on medical prescription for renewable delivery |
| Distribution | Supply through pharmacies (community) |
| Advertising to general public | not allowed |
| ATC Code | A10BD07 |
| Marketing status | Never marketed |
| SmPC | download |
| PL | download |
| Public Assessment Report | download |
| Summary of risk management plan | download |